[DOI] [PMC free article] [PubMed] [Google Scholar] 153.Pugh M.E., Newman J.H., Williams D.B., Brittain E., Robbins I.M., Hemnes A.R
Our study suggests that besides obesity and diabetes, GLP-1-agonists may also help in the treatment of alcohol and substance use disorders
Glorie, L
The grafts from non-heart-beating donors are treated with 25 mg/kg of glycine during normothermic recirculation to decrease reperfusion injury to endothelial cells and parenchymal cells after organ transplantation [55]
Clinically, glycine has been used as a component of total parenteral nutrition and has been investigated in various therapeutic contexts
The technology allows patients living with Alzheimers disease, intellectual and developmental disabilities, autism, and traumatic brain injuries to live more independently